News

60 Minutes, the poliovirus, and Breakthrough Therapy Designation Since the news program “60 Minutes” first aired two segments in March 2015 focused on an early-phase clinical trial taking place at Duke University, a lot of excitement has been generated about the investigational treatment highlighted: PVS-RIPO – more commonly referred to as the re-engineered poliovirus. The excitement was well-warranted, as the results reported at […] May 13, 2016

So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […] March 14, 2016